X T L Biopharmaceuticals reported $166K in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Bioline Rx USD 38.8M 2.11M Mar/2026
Teva Pharmaceutical Industries USD 39.86B 183M Jun/2026
X T L Biopharmaceuticals USD 166K 548K Dec/2025